Document Detail


Superficial femoral artery plaque, the ankle-brachial index, and leg symptoms in peripheral arterial disease: the walking and leg circulation study (WALCS) III.
MedLine Citation:
PMID:  21436300     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The clinical significance of magnetic resonance-imaged plaque characteristics in the superficial femoral artery (SFA) is not well established. We studied associations of the ankle-brachial index (ABI) and leg symptoms with MRI-measured plaque area and percent lumen area in the SFA in participants with and without lower-extremity peripheral arterial disease (PAD).
METHODS AND RESULTS: Four hundred twenty-seven participants (393 with PAD) underwent plaque imaging of the first 30 mm of the SFA. Twelve 2.5-mm cross-sectional images of the SFA were obtained. Outcomes were normalized plaque area, adjusted for artery size (0 to 1 scale, 1=greatest plaque), and lumen area, expressed as a percent of the total artery area. Adjusting for age, sex, race, smoking, statins, cholesterol, and other covariates, lower ABI values were associated with higher normalized mean plaque area (ABI <0.50:0.79; ABI 0.50 to 0.69:0.73; ABI 0.70 to 0.89:0.65; ABI 0.90 to 0.99:0.62; ABI 1.00 to 1.09:0.48; ABI 1.10 to 1.30:0.47 (P trend <0.001)) and smaller mean percent lumen area (P trend <0.001). Compared with PAD participants with intermittent claudication, asymptomatic PAD participants had lower normalized mean plaque area (0.72 versus 0.65, P=0.005) and larger mean percent lumen area (0.30 versus 0.36, P=0.01), adjusting for the ABI and other confounders.
CONCLUSIONS: Lower ABI values are associated with greater MRI-measured plaque burden and smaller lumen area in the first 30 mm of the SFA. Compared with PAD participants with claudication, asymptomatic PAD participants have smaller plaque area and larger lumen area in the SFA. Clinical Trial Registration- URL: http://www.clinicaltrials.gov. Unique identifier: NCT00520312.
Authors:
Mary M McDermott; Kiang Liu; James Carr; Michael H Criqui; Lu Tian; Debiao Li; Luigi Ferrucci; Jack M Guralnik; Christopher M Kramer; Chun Yuan; Melina Kibbe; William H Pearce; Jarett Berry; Walter McCarthy; Yihua Liao; Dongxiang Xu; Jennifer Orozco; Timothy J Carroll
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2011-03-24
Journal Detail:
Title:  Circulation. Cardiovascular imaging     Volume:  4     ISSN:  1942-0080     ISO Abbreviation:  Circ Cardiovasc Imaging     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-05-18     Completed Date:  2011-08-17     Revised Date:  2012-05-02    
Medline Journal Info:
Nlm Unique ID:  101479935     Medline TA:  Circ Cardiovasc Imaging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  246-52     Citation Subset:  IM    
Affiliation:
Department of Medicine, Northwestern University’s Feinberg School of Medicine, Chicago, IL, USA. mdm608@northwestern.edu
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00520312
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Ankle Brachial Index*
Female
Femoral Artery / pathology*
Humans
Leg / blood supply*
Lipoproteins / blood
Magnetic Resonance Imaging*
Male
Peripheral Arterial Disease / blood,  diagnosis,  pathology*,  physiopathology
Plaque, Atherosclerotic / pathology*
Walking
Grant Support
ID/Acronym/Agency:
R01 HL083064-01A2/HL/NHLBI NIH HHS; R01 HL083064-02/HL/NHLBI NIH HHS; R01 HL083064-03/HL/NHLBI NIH HHS; R01 HL083064-04/HL/NHLBI NIH HHS; R01 HL088589-01A1/HL/NHLBI NIH HHS; R01-HL083064/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Lipoproteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Smoking in Pregnancy and Parenting Stress: Maternal Psychological Symptoms and Socioeconomic Status ...
Next Document:  Genome-wide association studies and type 2 diabetes.